On February 27, 2018 Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, reported that Mark C. Capone, president and CEO, is scheduled to present at two upcoming investor conferences (Press release, Myriad Genetics, FEB 27, 2018, View Source [SID1234524246]). On March 13, 2018, Mr. Capone will present at the 38th annual Cowen Healthcare Conference in Boston, Massachusetts at 8:40 a.m. ET. On March 14, 2018, Mr. Capone will present at the Barclays Global Healthcare Conference in Miami, Florida at 2:35 p.m. ET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The presentations will be available to interested parties through a live audio webcast accessible through a link in the investor information section of Myriad’s website at www.myriad.com.